Want to see BTAIQ full AI Analyst Report?
Bioxcel Therapeutics (BTAIQ) Revenue
Bioxcel Therapeutics Revenue
Bioxcel Therapeutics had a revenue of 182.00K in the quarter ending Jun 30, 2026, with -11.65%. This bring the company's revenue in the last twelve months to 742.00K, Increased 9.12%. In the fiscal year ending Dec 31, 2025, Bioxcel Therapeutics had annual revenue of 642.00K with -71.67% growth.
- Revenue (ttm)
- 742.00K
- Revenue Growth
- -14.52%
- P/S Ratio
- 0.63
- Revenue/Employee
- $22,138
- Employees
- 29
- Market Cap
- $406.97K
Revenue Chart
Bioxcel Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 642.00K | -1.62M | -71.67% |
| Dec 31, 2024 | 2.27M | 886.00K | 64.20% |
| Dec 31, 2023 | 1.38M | 1.00M | 268.00% |
| Dec 31, 2022 | 375.00K | 375.00K | ― |
| Dec 31, 2021 | 0.00 | 0.00 | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.